参考文献

1.Ameen R，Al-Shemmari S，Al-Humood S，et al.RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients.Transfusion，2003，43：1604-1610.

2.Berdoukas VA，Kwan YL，Sansotta ML.A study on the value of red cell exchange transfusion in transfusion dependent anaemias.Clin Lab Haematol，1986，8：209-220.

3.Cazzola M，De Stefano P，Ponchio L，et al.Relationship between transfusion regimen and suppression of erythropoiesis in beta-thalassaemia major.Br J Haematol，1995，89：473-478.

4.Cazzola M，Borgna-Pignatti C，Locatelli F，et al.A moderate transfusion regimen may reduce iron loading in beta- thalassemia major without producing excessive expansion of erythropoiesis.Transfusion，1997，37：135-140.

5.Cohen AR，Glimm E，Porter JB.Effect of transfusional iron intake on response to chelation therapy in thalassemia major.Blood，2008，111：583-587.

6.Cheng CK，Lee CK，Lin CK.Clinically significant red blood cell antibodies in chronically transfused patients：a survey of Chinese thalassemia major patients and literature review.Transfusion，2010，52：2220-2224.

7.Davies P，Robertson S，Hegde S，et al.Calculating the required transfusion volume in children.Transfusion，2007，47：212-216.

8.Friedman DF，Jawad AF，Martin MB，et al.Erythrocytapheresis to reduce iron loading in thalassemia.Blood，2003，102：121a.

9.Graziano JH，Piomelli S，Hilgartner M，et al.Chelation therapy in beta-thalassemia 9.major.III.The role of splenectomy in achieving iron balance.J Pediatr，1981，99：695-699.

10.Klein HG，Spahn DR，Carson JL.Red blood cell transfusions in clinical practice.Lancet，2007，370：415-436.

11.Michail-Merianou V，Pamphili-PanousopoulouL，Piperi-Lowes L，et al.Alloimmunization to red cell antigens in thalassemia：comparative study of usual versus better-match transfusion programmes.Vox Sang，1987，52：95-98.

12.Milkins C，Berryman J，Cantwell C，et al.Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories.British Committee for Standards in Haematology.Transfus Med，2013，23：3-35.

13.Modell B.Total management of thalassaemia major.Arch Dis Childhood，1977，52：485-500.

14.O’Brien RT，Pearson HA，Spencer RP.Transfusion-induced decrease in spleen size in thalassemia major：documentation by radioisotopic scan.J Pediatr，1972，81：105-107.

15.Pelletier JP，Transue S，Snyder EL.Pathogen inactivation techniques.Best Pract Res Clin Haematol，2006，19：205-242.

16.Rebulla P，Modell B.Transfusion requirements and effects in patients with thalassaemia major.Cooleycare Programme.Lancet，1991，337：277-280.

17.Singer ST，Wu V，Mignacca R，et al.Alloimmunization and erythrocyte autoimmunization in transfusiondependent thalassemia patients of predominantly Asian descent.Blood，2000，96：3369-3373.

18.Spanos T，Karageorga M，Ladis V，et al.Red cell alloantibodies in patients with thalassemia.Vox Sang，1990，58：50-55.

19.Spanos T，Ladis V，Palamidou F，et al.The impact of neocyte transfusion in the management of thalassaemia.Vox Sang，1996，70：217-223.

20.Solheim BG.Pathogen reduction of blood components.TransfusApher Sci，2008，39：75-82.

21.Swanson K，Dwyre DM，Krochmal J，et al.Transfusion-related acute lung injury 21.（TRALI）：current clinical and pathophysiologic considerations.Lung，2006，184：177-185.

22.Thompson AA，Cunningham MJ，Singer ST，et al.Red cell alloimmunization in a diverse population of patients with thalassaemia.Br J Haematol，2011，153：121-128.

23.Vlaar APJ，Juffermans NP.Transfusion-related acute lung injury：a clinical review.Lancet，2013，382：984-994.